On a High Note: I’m Buying More Alto, Taking Aim at Another Stock
Here’s why I’m buying more Alto Ingredients, and looking to gun it for this stock.
Sticking With This Alto Ingredients Price Target Amid Turnaround
The small-cap firm enjoyed some strong results.
Inseego Reports, and My Question Is: What Was I Thinking?!
Here’s how I’m handling this holding after a dismal report … and why I’m adding to another name that has the right ‘ingredients.’
Buying More Rocket Lab After $397 Million Update
The aerospace firm has been awarded a significant contract by the U.S. Space Force.
The $10K Portfolio: Gunnin’ for Some More Smith & Wesson
As gun ownership appears to be on the rise, I’m adding to this weapons maker. Also, I’m eyeing an exit for this stock.
Sticking With This Ocular Therapeutix Price Target as Key Treatment Moves Forward
The small-cap healthcare firm offered some encouraging earnings results.
Adding to a Couple of Troubled Positions as July Comes to a Close
Here’s our trading plan for Friday and the upcoming earnings calendar for portfolio names.
Cutting SoFi as ‘Misleading’ Report Continues to Weight on Share Price
The financial services firm has taken a turn for the worse.
Our Small-Cap Drone Name Faces Opportunity After DoD Ramp Up Report
Though shares on under pressure on the news, there’s no long-term concern.
Selling 5 Small-Cap Names for a LIFO Profit
We looked to take advantage of some pre-earnings weakness and now we’re ready to profit.